SB
Samsara BioCapital Portfolio holdings
AUM
$489M
1-Year Return
135.25%
This Quarter Return
-22.13%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$395M
AUM Growth
-$107M
(-21%)
Cap. Flow
+$43.8M
Cap. Flow
% of AUM
11.07%
Top 10 Holdings %
Top 10 Hldgs %
64.49%
Holding
56
New
7
Increased
4
Reduced
3
Closed
–
Top Buys
| 1 |
Arcellx
ACLX
|
$14M |
| 2 |
Zymeworks
ZYME
|
$6.36M |
| 3 |
ALX Oncology
ALXO
|
$4.44M |
| 4 |
Scholar Rock
SRRK
|
$4.38M |
| 5 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$4.37M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$4.57M |
| 2 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$345K |
| 3 |
Nkarta
NKTX
|
$11 |
Sector Composition
| 1 | Healthcare | 97.99% |
| 2 | Financials | 2.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
VistaGen Therapeutics
VTGN
$114M
| $606K | 0.15% |
16,288
| – | – |
|
|
KRON
52
DELISTED
Kronos Bio
KRON
| $565K | 0.14% |
78,131
| – | – |
|
|
KLRS
53
Kalaris Therapeutics, Inc. Common Stock
KLRS
$83.4M
| $556K | 0.14% |
3,580
| – | – |
|
|
NGM
54
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $208K | 0.05% |
13,669
| – | – |
|
55
Astria Therapeutics
ATXS
$391M
| $168K | 0.04% |
25,000
| – | – |
|
|
AMRN
56
Amarin Corp
AMRN
$307M
| $82K | 0.02% |
1,250
| – | – |
|